Showing results (621-630 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|September 19, 2007
Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus statusOlivier Reelfs, Yao-Zhong Xu, Andrew Massey, et al.
Molecular Cancer Therapeutics|September 19, 2007
Histone deacetylase inhibitors selectively suppress expression of HDAC7Milos Dokmanovic, Gisela Perez, Weisheng Xu, et al.
Molecular Cancer Therapeutics|September 19, 2007
Kaempferol induces apoptosis in glioblastoma cells through oxidative stressVivek Sharma, Christy Joseph, Soumya Ghosh, et al.
Molecular Cancer Therapeutics|September 19, 2007
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in miceMaarten Van Roy, Philippe Van Lint, Ineke Van Laere, et al.
Molecular Cancer Therapeutics|September 19, 2007
Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathwayLi-Hua Chen, Jing Fang, Huaixing Li, et al.
Molecular Cancer Therapeutics|December 7, 2006
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic mannerFatima Cardoso, Virginie Durbecq, Jean-François Laes, et al.
Molecular Cancer Therapeutics|July 15, 2004
Role of the transcription factor Ets-1 in cisplatin resistanceLeigh A Wilson, Hirotaka Yamamoto, Gurmit Singh
Molecular Cancer Therapeutics|July 15, 2004
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cellsCheng Jiang, Hongbo Hu, Barbara Malewicz, et al.
Molecular Cancer Therapeutics|August 10, 2004
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational applicationKyoung Jin P Yoon, Janice L Hyatt, Christopher L Morton, et al.
Molecular Cancer Therapeutics|August 10, 2004
Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibodyAlexander L Rakhmilevich, Andrea T Hooper, Daniel J Hicklin, et al.
Pageof 599